Management of H1N1 influenza virus respiratory syndrome

Minerva Anestesiologica

Volumn 75, Issue 11, 2009, Pages 654-660

  De Rosa, F G ^a   Montrucchio, C ^a   Di Perri, G ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Diagnosis; Infection control; Influenza A virus; Influenza vaccines

Indexed keywords

AMANTADINE; ANTIBIOTIC AGENT; CORTICOSTEROID; INFLUENZA VACCINE; OSELTAMIVIR; PARACETAMOL; RIMANTADINE; ZANAMIVIR;

ABNORMAL BEHAVIOR; ADULT RESPIRATORY DISTRESS SYNDROME; BRONCHOPNEUMONIA; BRONCHOSPASM; CLINICAL FEATURE; COMMUNITY ACQUIRED PNEUMONIA; COMORBIDITY; CONFUSION; HIGH RISK POPULATION; HUMAN; INFECTION CONTROL; INFLUENZA; INFLUENZA A (H1N1); INFLUENZA VIRUS A H1N1; INTENSIVE CARE UNIT; ITALY; MEXICO; OTITIS MEDIA; OXYGEN SATURATION; PNEUMONIA; RECOMMENDED DRUG DOSE; RESPIRATORY TRACT INFECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; STAPHYLOCOCCUS AUREUS; TREATMENT DURATION; VACCINATION;

HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; INTENSIVE CARE UNITS;

EID: 72449209709     PISSN: 03759393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Trifonov V, Khiabanian H, Greenbaum B, Rabadan R. The origin of the recent swine influenza A (H1N1) virus infecting humans. Euro Surveill 2009;14:17.
2. Rizzo C, Declich S, Bella A, Caporali MG, Lana S, Pompa MG et al. Enhanced epdeimiological surveillance of influenza A (H1N1) in Italy. Euro Surveill 2009;14:1-4.
3. CDC. Intensive-care patients with severe novel Influenza (H1N1) virus infection - Michigan, June 2009. MMWR Morb Mortal Wkly Rep 2009;58:749-752
4. Rello J, Rodriguez A, Ibanez P, L. Socias, J. Cebrian, A. Marques et al. Intensive care adult patients with severe respiratory failure caused by Influenza A (H1N1)v in Spain. Critical Care 2009 [Epub ahead of print].
5. World Health Organization. Clinical management of human infection with new influenza A (H1N1) virus: initial guidance. [cited 2009 October 9]. Available at: http://www.who.int.
6. Centers for Disease Control and Prevention. [cited 2009 October 9]. Available at: www.cdc.gov
7. Istituto Superiore di Sanità. [cited 2009 October 9]. Available at: www.iss.it.
8. World Health Organization. WHO guidelines for pharmacological management of pandemic (H1N1) 2009 influenza and other influenza viruses. [cited 2009 October 9]. Available at: http://www.who.int/csr/disease/swineflu/en/index.html
9. CDC. New human influenza A (H1N1) virus infections in Mexico and other affected countries: clinical observations. Wkly Epidemiol Rec 2009;84:185-196
10. Kelly H, Grant K. Interim analysis of pandemic influenza (H1N1) 2009 in Australia: Surveillance trends, age of infection and effectiveness of seasonal vaccination. Euro Surveill 2009;14:1-5.
11. Hahnè S, Donker T, Maijer A, A Timen, J van Steenbergen, A Osterhaus et al. Epidemiology and control of influenza A (H1N1)v in the Netherlands: The first 115 cases. Euro Surveill 2009;14:1-4.
12. CDC. Intensive care patients with severe novel influenza A (H1N1) virus infection. - California, April-May 2009. MMWR Morb Mortal Wkly Rep 2009;2009:470-472
13. CDC. Surveillance for pediatric deaths associated with 2009 pandemic influenza A (H1N1) virus infection - United States, April-August 2009. MMWR Morb Mortal Wkly Rep 2009;58:941-947
14. CDC. 2009 pandemic influenza A (H1N1) virus infections - Chicago, Illinois, April-July 2009. MMWR Morb Mortal Wkly Rep 2009;58:913-918
15. Burch J, Corbett M, Stock C, Nicholson K, Elliot AJ, Duffy S et al. Prescription of anti-influenza drugs for healthy adults: a systematic review and meta-analysis. Lancet Infect Dis 2009;9:537-545
16. Jamieson DJ, Honein MA, Rasmussen SA, Williams JL, Swerdlow DL, Biggerstaff MS et al. H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet 2009;374:451-458
17. Tanaka T, Nakajima K, Murashima A, Garcia-Bournissen F, Koren G, Ito S. Safety of neuraminidase inhibitors against novel influenza A (H1N1) in pregnant and breastfeeding women. CMAJ 2009;181:55-58
18. Koliou M, Soteriades ES, Toumasi MM, Demosthenous A, Hadjidemetriou A. Epidemiological and clinical chracteristics of influenza A (H1N1)v infection in children: the first 45 cases in Cyprus, June-August 2009 . Euro Surveill 2009;14:1-4.
19. Burch JPM, Conti S et al. for the CRD/CHE Technology Assessment Group (Centre for Reviews and Dissemination/ Centre for HEalth Economics. Influenza-zanamivir, amantadine and oseltamivir (review): assessment report. [cited 2009 October 9]. Available at: http://ww.nice.org.uk/Guidance/ TA168.
20. Blumentals WA. The safety of oseltamivir in patients with influena: analysis of healthcare claims data from six influenza seasons. Medscape General Medicine 2007;9:23.
21. Gums JG, Blumentals WA. Oseltamivir and influenza-related complications, hospitalization and healthcare expenditure in healthy adults and children. Expert Opin Pharmacother 2008;9:151-161
22. CDC. Oseltamivir-resistant 2009 Pandemic (H1N1)v Influenza A virus infection in two summer campers receiving prophylaxis - North Carolina 2009. MMWR Morb Mortal Wkly Rep 2009;58:969-972
23. Cole JA, Loughlin JE, Ajene AN, Rosenberg DM, Cook SF, Walker AM. The effect of zanamivir treatment on influenza complications: A retrospective cohort study. Clinical Therapeutics 2002;24:1824-1839 (Pubitemid 35440953)
24. Hurt AC, Ernest J, Deng YM, Iannello P, Besselaar TG, Birch C et al. Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in Oceania, South East Asia and South Africa. Antiviral Research 2009;83:90-93
25. Kidd IM, Down J, Nastouli E, Shulman R, Grant PR, Howell DC et al. H1N1pneumonitis treated with intravnous zanamivir. Lancet 2009;374:1036.
26. Harper SA, Bradley JS, Englund JA, File TM, Gravenstein S, Hayden FG et al. Seasonal Influenza in adults and children-diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the infectious diseases society of america. Clinical Infectious Diseases 2009;48:1003-1032
27. Abdel-Ghafar AN, Chotpitayasunondh T, Gao Z, Hayden FG, Nguyen DH, de Jong MD et al. Update on Avian Influenza A (H5N1) virus infection in humans. N Engl J Med 2008;358:261-273
28. McGeer A, Green KA, Plevneshi A, Shigayeva A, Siddiqi N, Raboud J et al. Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada. Clin Infect Dis 2007;45:1568-1575
29. Kollef MH, Morrow LE, Baughman RP, Craven DE, McGowan JE Jr, Micek ST et al.Health care-associated pneumonia (HCAP): A critical appraisal to improve identification, management, and outcomes-proceedings of the HCAP summit. Clin Infect Dis 2008;46:S296-S334.
30. Sandrock C, Stollenwerk N. Acute febrile respiratory illness in the ICU - Reducing disease transmission. Chest 2008;133:1221-1231 (Pubitemid 351685530)
31. Sandrock CE. Severe febrile respiratory illnesses as a cause of mass critical care. Respiratory Care 2008;53:40-53.
32. Daugherty EL. Health care worker protection in mass casualty respiratory failure: Infection control, decontamination, and personal protective equipment - Discussion. Respiratory Care 2008;53:212-214
33. Antonelli M, Conti G, Esquinas A, Montini L, Maggiore SM, Bello G et al. A multiple-center survey on the use in clinical practice of noninvasive ventilation as a first-line intervention for acute respiratory distress syndrome. Crit Care Med 2007;35:18-25. (Pubitemid 46035672)
34. Muller MP, McGeer A. Febrile respiratory illness in the intensive care unit setting: an infection control perspective. Curr Opin Crit Care 2006;12:37-42.
35. Christian MD, Poutanen SM, Loutfy MR, Muller MP, Low DE. Severe acute respiratory syndrome. Clin Infect Dis 2004;38:1420-1427
36. Christian MD, Loutfy M, McDonald C, Martinez KF, Ofner M, Wong T et al. Possible SARS coronavirus transmission during cardiopulmonary resuscitation. Emerg Infect Dis 2004;10:287-293 (Pubitemid 38176971)
37. Hui DS, Hall SD, Chan MTV, Chow BK, Tsou JY, Joynt GM et al. Noninvasive positive-pressure ventilation - An experimental model to assess air and particle dispersion. Chest 2006;130:730-740